Abstract:

We studied 1400 cases of CNS cysticercosi s. 1064 were male, and 336 female, with 62.6% between the age of 31 and 45 years. According to the classification standard of our country, we divided our cases into epileptic type 561 cases’ subarachnoid tyPe 126 cases’ cerebral parenchymal type 184 cases’ intraventicular type 102 cases’ mixed tyPe 419 cases and asymptomatic type 5 cases. Epilepsy was the most common symptom. Meningitiis or adhesive arachonoiditis was the most catastrophic complication of neurocysticercosis. Other less common manifestations were stroke, encephalitis, headache without hydrocephalus or cerebral parenchymal inflamation or isolated large cyst. These cyst may mimic intracranial tumors and present a greater diagnostic challenge. Virtually the CT Scan is the most useful test in diagnosing neurocysticercosis. praziquante was effective clinical improvement occurred in 64.4%. There is no doubt that the use of praziquantel represents a major advance in the treatment of neurocysticercosis,